Raman Pharma is a UK based MHRA and VMD Licensed Wholesaler supplying to the Human and Veterinary Market. We are a family run company ambitiously changing the face of the Pharmaceutical and Veterinary Market alike in order to serve the needs of our customers and their patients.
Our Philosophy and business are structured around the requirements of our customers and we are committed to giving them our upmost attention and care. We believe in delivering quality and value to our customers wherever they may be.
The Herbal Horse and Pet is a South African manufacturer of a very innovative range of supplements for horses, dogs and cats. Their philosophy of using a large number of different ingredients in small amounts mimics nature in that the healing effect of the ingredients is maximised while undesirable side-effects are minimised. These unique formulations, in conjunction with 21st century scientific research and techniques are what they call “cutting edge nature”.
They are manufactured in a GMP Compliant Factory and has a large following from riders and pet owners across the world. Please follow the link to the website – www.theherbalhorse.co.uk to see all the amazing blogs and the ability to purchase these products online. The Equine and Pet Range were introduced to the UK Market in September 2014 by Raman Pharma to give the UK a taste of the future in equine and companion animal nutritional supplements.
The Government has temporarily suspended the requirement for patients (or their representatives) to sign the back of NHS prescription forms or EPS tokens. This change comes into effect from 1st November 2020 and will last initially until 31st March 2021. As part of the social distancing measures to limit the spread of the coronavirus and to assist in...
Fluphenazine decanoate 25mg/1ml and 100mg/1ml solutions for injection ampoules (Modecate and Modecate Concentrate) manufactured by Sanofi, have been discontinued for some time and stock of any remaining batches will now have expired. Prescribers should complete arrangements to transfer patients on Modecate to therapeutic alternatives under medical supervision. Fluphenazine injections are available as unlicensed imports and any prescriptions issued...
Department of Health and Social Care (DHSC) has today (30/10/2020) set the FINAL price concessions for October 2020. The new additions to the October 2020 price concession list are below: Drug Pack Size Price Concession Chlorphenamine 4mg tablets 28 £2.30 Ciprofloxacin 500mg tablets 10 £6.79 Desmopressin 10micrograms/dose nasal spray 60 dose £22.41 Duloxetine 30mg gastro-resistant...
From 1st November 2020, the NHS Community Pharmacist Consultation Service (CPCS) is being extended across England to include referrals from general practices as well as from NHS 111. GPs will be able to refer patients to community pharmacies to receive a CPCS consultation for minor illness (unlike NHS 111, GPs cannot refer patients for an...
Drug Alert Number EL (20) A/50 This alert has been updated to include an additional batch detailed below: AlfaD 0.25 microgram capsules PL 49876/0001 Batch Number Expiry Date Pack Size First Distributed A04279A 31 Jan 2022 30 26 Mar 2020 Class 3 Medicines recall: AlfaD Capsules (Theramex) Drug alert number: EL (20) A/46 Date issued:...
From April 2021, the Drug Tariff will no longer be printed and distributed by the NHS Business Services Authority (NHSBSA). The Preface section of the November 2020 Drug Tariff has been updated to reflect that March 2021 will be the final month in which a printed Drug Tariff will be circulated to community pharmacies. From January 2021, where pharmacy...
The new FreeStyle Libre 2 Sensors recently launched by Abbott Diabetes Care Ltd have been added to the Appliances section in Part IXA of the November 2020 Drug Tariff and included in the list of Drugs for which Discount is Not Deducted (DND). The introduction of the second-generation FreeStyle Libre 2 Flash Glucose Monitoring system...
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Haloperidol 5mg/5ml poral solution sugar free (Thame Laboratories) Haloperidol 5mg/5ml poral solution sugar free (Thame Laboratories) will be out of stock until March 2021 Limited supplies remain available from Pinewood Healthcare however they are unable to support any uplift in demand....
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Nalcrom (sodium cromoglicate) 100mg capsules Nalcrom 100mg capsules will be out of stock until late November 2020 Unlicensed imports of sodium cromoglicate 100mg capsules have been sourced, the following specialist importers have confirmed they can source unlicensed sodium cromoglicate 100mg capsules...
Update: 28/10/2020 Resupply date now expected to be January 2021 Department of Health and Social Care (DHSC) has issued a medicine supply notification for Prednisolone 5mg suppositories. Prednisolone 5mg suppositories are out of stock until end of July 2020 due to manufacturing issues. Unlicensed supplies of prednisolone 5mg suppositories have been sourced, lead times will...
Users of Safe and Sound Infrared Ear Thermometers are being urged by the MHRA to check their product code and lot number due to a voluntary product recall of specific lots initiated by the company due to a fault.
Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients.
We want your comments on the clarity and wording of our new guidance
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
How to make a payment to MHRA by credit or debit card or a bank transfer.
Theramex Ireland Ltd T/A Theramex HQ UK Ltd has informed us of an issue related to error in the decommissioning of a further batch. Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘EXPORT’. This is a second alert for further batches identified.
List of manufacturers and their medical devices which have been granted an exemption by the MHRA. The list also includes manufacturers whose exemption expired or was cancelled. This information will be listed for 2 months after expiry or cancellation.
New routes for assessment including an accelerated procedure and rolling review.
How the MHRA will process variations to Marketing Authorisations (MAs) from 1 January 2021.
The process for applicants applying for a Paediatric Investigation Plan (PIP) waiver from 1 January 2021.
This guidance summarises our approach to pharmacovigilance from 1 January 2021.
The way Marketing Authorisations (MAs) are processed will change from 1 January 2021.
List of field safety notices (FSNs) from medical device manufacturers from 19 to 23 October 2020.
Medicines that were granted a positive opinion under the early access to medicines scheme (EAMS) which has now expired.
Renewal of EAMS scientific opinion issued to Santhera Pharmaceuticals for Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy, including the public assessment report.
How to prepare for implementation and compliance of the Safety Features Regulation.
A letter providing guidance on the post-transition conversion process was sent by email on 23 October 2020 to the Community MA holders.
A flyer to circulate to customers alongside a field safety notice covering what it is and why it's important to take action.
Pharmacovigilance system requirements from 1 January 2021
US-licensed flu vaccine (Flublok) to be used as part of the UK’s 2020/21 seasonal flu programme
Details of the prosecution of Ms Susan Bello-Pearson trading as Dezinerpugz Limited (previously Dezinerbullz), Essex
Details of the seizure notice served to Susan Bello-Pearson, Dezinerbullz Ltd, Essex in January 2018.
Details of the seizure notice served to Susan Bello-Pearson, Dezinerbullz Ltd, Chelmsford, Essex in April 2018.
Guidance for the pharmaceutical industry on importing and exporting veterinary medicines post transition period.
Licences, certificates and special rules for bringing goods into the UK from 1 January 2021.
Guidance for veterinary medicines manufacturers and wholesale dealers in GB on selling and supplying products placed on the EU and UK markets before 1 January 2021 and the evidence you may need to provide.
Details of the seizure notice served to Element Bullys Ltd, Plymouth in May 2019. This notice is published following the conclusion of an investigation case.
Details of the prosecution of Mr Michael Dawson, trading as Element Bullys Limited, Plymouth.
Guidance for the veterinary pharmaceutical industry on how to convert a Centrally Authorised Product (CAP) to a national GB Marketing Authorisation.
Guidance for the veterinary pharmaceutical industry on Pharmacovigilance reporting. This guidance will be updated with more information as it becomes available.
Guidance for the veterinary pharmaceutical industry on Detailed Description of Pharmacovigilance System (DDPS) and Qualified Person for Pharmacovigilance (QPPV).
Details of the improvement notice served to Wynnstay Group, Llansantffraid, Powys.
For a marketing authorisation holder only; how to report a defect with a veterinary medicine.
The procedure for reporting and the types of product defects reports received by the VMD between 2016 and 2019.
Reporting against VMD published standards up to 31 March 2021
Guidance for the pharmaceutical industry on location and other authorised personnel requirements post transition period.
Report of the ten products for which most Special Import Certificates (SIC) have been issued by VMD in the UK.
How to legally run a business that deals with the wholesale of animal medicines (veterinary medicinal products) and the WDA Register.
Product defect recall alert for: Gallifen 200 mg/ml Suspension for Chickens and Pheasants (Vm 30282/4037), Pigfen 200 mg/ml Suspension for Pigs (Vm 30282/4038) by Huvepharma N.V
VMD Published Standards for regulatory work 2020-2021 against Key performance indicators (KPIs)
Findings come from new research funded by Cancer Research UK and NIHR
Drug significantly eliminated oral corticosteroid (OCS) in OCS-dependent asthma patients
The UK BIA Antibody Taskforce is set to take combinations into further development as a cocktail
Collaboration includes two therapeutic candidates - MP0420 and MP0423
French pharma will test investigational candidate alongside MSD’s Keytruda
New guidance based on research from University of Manchester
Agreement will also see companies develop treatments for frontotemporal dementia
Acquisition will enable Base Genomics to accelerate clinical and commercial development
Agreement will see vaccine developers make available 200 million doses
FDA action date for regulatory decision set during first quarter of 2021
Process can help to reduce the time to authorisation of the vaccine
Strategic research agreement announced with Milton Keynes University Hospital Foundation Trust
Investigational oral treatment is being investigated in C3 glomerulopathy
Drug authorised for use in non-metastatic castration-resistant prostate cancer
Trial was paused in September following participant illness
Unit 2 Fleet Business Park, Sandy Lane, Church Crookham, Fleet, Hampshire, GU52 8BF
Pharmaceutical and Veterinary Licensed Distributor. WDA (H) 43703 & WDA (V) 43703.
- +44 (0)1252 260 460.
- +44 (0)1276 469 290
Monday to Friday - 09:30 – 18:30
Saturday & Sunday - Closed, Online Ordering Available